IGFL2-AS1 promoted gastric cancer development via a signaling axis involving the microRNA, miR-802, and cAMP-regulated phosphoprotein 19 (ARPP19) [36], and was found to predict poor prognosis in ccRCC [37]. The gene discussed is IGFL2; the disease is gastric cancer.